Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gaush Meditech Ltd Earnings Release 2025

Mar 16, 2026

50577_rns_2026-03-16_854b32a5-476b-44de-bed7-4dc9a961cc9e.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

高视 GAUSH

Gaush Meditech Ltd

高视医疗科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2407)

NOTICE OF BOARD MEETING

The board (the "Board") of directors (the "Director(s)") of Gaush Meditech Ltd (the "Company", together with its subsidiaries, the "Group") hereby announces that a meeting of the Board will be held on Thursday, March 26, 2026 for the purpose of, among other matters, considering and approving the annual results of the Group for the year ended December 31, 2025 and its publication, and considering the recommendation for payment of a final dividend (if any).

By order of the Board

Gaush Meditech Ltd

Mr. Gao Tieta

Chairman and Executive Director

Hong Kong, March 16, 2026

As at the date of this announcement, the Board comprises Mr. Gao Tieta as Chairman and executive Director, Mr. Liu Xinwei, Mr. Zhao Xinli, Mr. Zhang Jianjun and Ms. Li Wenqi as executive Directors, Dr. David Guowei Wang as non-executive Director, and Mr. Feng Xin, Mr. Wang Li-Shin and Mr. Chan Fan Shing as independent non-executive Directors.